Ipca Labs receive USFDA nod for Propranolol Hydrochloride tablets

New Delhi, June 4 (UNI) Ipca Laboratories Ltd today said it has received approval from the US Food and Drugs Administration to manufacture Propranolol Hydrochloride tablets.

The approval has been received for manufacturing Propranolol Hydrochloride Tablets in the strengths of 10 mg, 20 mg, 40 mg, 60 mg and 80 mg for the US market, a company statement said.

Total annual market sales for the tablets in the US were 24.1 million dollars, it added.

UNI SR PDT DS1445